FR7348M - - Google Patents

Info

Publication number
FR7348M
FR7348M FR141218A FR141218A FR7348M FR 7348 M FR7348 M FR 7348M FR 141218 A FR141218 A FR 141218A FR 141218 A FR141218 A FR 141218A FR 7348 M FR7348 M FR 7348M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR141218A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR141218A priority Critical patent/FR7348M/fr
Application granted granted Critical
Publication of FR7348M publication Critical patent/FR7348M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR141218A 1967-12-07 1968-02-26 Expired FR7348M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR141218A FR7348M (fr) 1967-12-07 1968-02-26

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR131260 1967-12-07
FR141218A FR7348M (fr) 1967-12-07 1968-02-26

Publications (1)

Publication Number Publication Date
FR7348M true FR7348M (fr) 1969-10-13

Family

ID=89430624

Family Applications (1)

Application Number Title Priority Date Filing Date
FR141218A Expired FR7348M (fr) 1967-12-07 1968-02-26

Country Status (1)

Country Link
FR (1) FR7348M (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190563A1 (fr) * 1985-01-14 1986-08-13 Boehringer Ingelheim Kg 12-Amino-pyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinolines, leur procédé de préparation et utilisation
EP0112739B1 (fr) * 1982-11-19 1989-02-22 Prodes S.A. Complexe (1:2) de 3-méthoxy-N-méthylmorphinane et l'acide théophylline acétique, son procédé de préparation et le complexe pour utilisation comme médicament
WO2002048144A1 (fr) * 2000-12-13 2002-06-20 Bayer Aktiengesellschaft Pyrrolo (2.1-a) dihydroisoquinolines et utilisation en tant qu'inhibiteurs de phosphodiesterase 10a

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112739B1 (fr) * 1982-11-19 1989-02-22 Prodes S.A. Complexe (1:2) de 3-méthoxy-N-méthylmorphinane et l'acide théophylline acétique, son procédé de préparation et le complexe pour utilisation comme médicament
EP0190563A1 (fr) * 1985-01-14 1986-08-13 Boehringer Ingelheim Kg 12-Amino-pyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinolines, leur procédé de préparation et utilisation
WO2002048144A1 (fr) * 2000-12-13 2002-06-20 Bayer Aktiengesellschaft Pyrrolo (2.1-a) dihydroisoquinolines et utilisation en tant qu'inhibiteurs de phosphodiesterase 10a

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
AU416737B2 (fr)
AU2277767A (fr)
AU342066A (fr)
AU610966A (fr)
AU2528767A (fr)
AU2256867A (fr)
AU2116667A (fr)
AU3189468A (fr)
AU3151267A (fr)
AU2454867A (fr)
AU2977667A (fr)
BE692779A (fr)
BE514578A (fr)
AU3054676A (fr)
AU2406369A (fr)
AU23366A (fr)
AU1763766A (fr)
AU34866A (fr)
AU408412B2 (fr)
AU1677166A (fr)
BE477645A (fr)
AU459699A (fr)
BE710087A (fr)
BE709541A (fr)